$432 Million is the total value of venBio Partners LLC's 8 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 11.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VENTYX BIOSCIENCES INC | $174,953,000 | +185.4% | 5,011,536 | 0.0% | 40.48% | +131.9% | ||
| ALXO | ALX ONCOLOGY HLDGS INC | $92,828,000 | +18.3% | 9,699,925 | 0.0% | 21.48% | -3.9% | |
| Sell | CINCOR PHARMA INC | $61,119,000 | +51.2% | 1,862,256 | -13.2% | 14.14% | +22.9% | |
| HRMY | Sell | HARMONY BIOSCIENCES HLDGS IN | $49,856,000 | -29.4% | 1,125,673 | -22.3% | 11.54% | -42.7% |
| AKRO | Sell | AKERO THERAPEUTICS INC | $20,310,000 | -1.0% | 596,483 | -72.5% | 4.70% | -19.6% |
| PHVS | Sell | PHARVARIS N V | $17,616,000 | -65.4% | 2,296,710 | -0.2% | 4.08% | -71.9% |
| IMPL | IMPEL PHARMACEUTICALS INC | $13,440,000 | -47.7% | 2,759,791 | 0.0% | 3.11% | -57.5% | |
| ELEV | ELEVATION ONCOLOGY INC | $2,109,000 | -19.3% | 1,866,339 | 0.0% | 0.49% | -34.4% | |
| VRNA | Exit | VERONA PHARMA PLCsponsored ads | $0 | – | -161,897 | -100.0% | -0.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERONA PHARMA PLC | 15 | Q2 2022 | 22.2% |
| AKERO THERAPEUTICS INC | 14 | Q3 2022 | 65.3% |
| ALX ONCOLOGY HLDGS INC | 13 | Q3 2023 | 73.8% |
| HARMONY BIOSCIENCES HLDGS IN | 13 | Q3 2023 | 21.1% |
| APELLIS PHARMACEUTICALS INC | 11 | Q2 2021 | 62.0% |
| PHARVARIS N V | 11 | Q3 2023 | 25.2% |
| IMPEL PHARMACEUTICALS INC | 10 | Q3 2023 | 7.3% |
| ELEVATION ONCOLOGY INC | 10 | Q3 2023 | 4.2% |
| VENTYX BIOSCIENCES INC | 8 | Q3 2023 | 42.7% |
| PRECISION BIOSCIENCES INC | 7 | Q3 2020 | 62.0% |
View venBio Partners LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View venBio Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.